Microsatellite instability is a biomarker for immune checkpoint inhibitors in endometrial cancer

In recent years, it has become evident that tumor cells have immune escape mechanisms, and immune checkpoint inhibitor therapy (anti-PD-1/PD-L1 antibody) has shown benefit in various cancers. In endometrial tumors with microsatellite-instability (MSI), somatic mutations have the potential to encode...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashita, Hitomi, Nakayama, Kentaro, Ishikawa, Masako, Nakamura, Kohei, Ishibashi, Tomoka, Sanuki, Kaori, Ono, Ruriko, Sasamori, Hiroki, Minamoto, Toshiko, Iida, Kouji, Sultana, Razia, Ishikawa, Noriyoshi, Kyo, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper: Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814165/
https://www.ncbi.nlm.nih.gov/pubmed/29464025
http://dx.doi.org/10.18632/oncotarget.23790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814165/
https://www.ncbi.nlm.nih.gov/pubmed/29464025
http://dx.doi.org/10.18632/oncotarget.23790

Ejemplares similares